Book a demo

Automated Visual Inspection Patents: Who Leads, Where the Gaps Are 2026

Automated Visual Inspection Patents: Who Leads, Where the Gaps Are 2026
Data to 2026-07-31

Automated Visual Inspection of Injectables: Patents Behind Reject-Rate and Defect-Classification Systems

77.6% concentration. The five most active assignees hold 38 of the 49 records in scope — a field with a narrow leading group rather than a broad crowd of filers. Filings rose from a single record in 2017 to a peak of 10 in 2024. The 2025 and 2026 figures will revise upward as later publications clear the roughly 18-month lag between filing and publication, so the apparent recent dip should not be read as declining interest.

Filing trend, 2017-2026
Complete Incomplete
Filing trend, 2017-202603581012017201820192020202120222023102024202532026Most recent year is partial — publication lag means later filings are not yet visible.
49
Published Records
78%
Top-5 Share of All Records
US
Leading Jurisdiction
23
Active Filers Ranked
Top filers · published records
  1. 1AMGEN INC23
  2. 2BUDD GERALD WALTER5
  3. 3MUSASHI AI NORTH AMERICA INC4
  4. 4PRESSCO TECH INC3
  5. 5NORDISCHER MASCHINENBAU RUD BAADER GMBH CO KG3
Published by Patsnap Research·

See the full automated visual inspection of injectables analysis in Eureka

  • The complete ranking, not just the top five
  • Every IPC branch with its share of the corpus
  • The most-cited records, and where claim space is still thin
Read more about this analysis in Eureka
FAQ

Common questions about this patent landscape

How concentrated is the patent landscape for automated visual inspection of injectables?+

It is fairly concentrated: the five most active assignees together hold 38 of the 49 records in scope, or 77.6% of the field. The top ten reach 93.9%. That leaves a long tail of single-filing entrants — mostly equipment specialists, individual inventors and at least one university — below the tenth position, so most companies entering this space are working around a small set of established filers rather than a crowded open field.

What technology areas dominate the patent claims in this field?+

Material analysis and testing (IPC class G01N) is the largest single category, covering 69.4% of the 49 records, followed by image data processing (G06T) at 38.8%. Container and apparatus classes such as A61J, B29C and A61M each cover under a fifth of records. AI-specific classes — G06N for computing models and G06V for image recognition — each sit at 12.2%, the smallest shares tracked, indicating the inspection hardware and methodology layer is far more heavily claimed than the classification software layer.

Is deep-learning-based defect classification still open for new patent filings?+

Based on this dataset, yes relative to the rest of the field: only 12.2% of the 49 records carry a G06N (AI computing) classification and the same share carries G06V (image/video recognition), against 69.4% for the underlying material-testing class. That does not mean the space is empty, but claim density there is markedly lower than around the core inspection hardware and methods, which is worth confirming with a freedom-to-operate search before committing to a specific classifier architecture.

Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.

Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.

Method: Filing trend and technology composition. Derived from a Patsnap search on Automated Visual Inspection of Injectables covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.